
Adult obesity increased to 28% of the US population in 2015 and the diabetes rate also climbed to 11.4%. Adults who are obese are 4.7 times more likely to be diabetic compared with adults with a normal weight

Adult obesity increased to 28% of the US population in 2015 and the diabetes rate also climbed to 11.4%. Adults who are obese are 4.7 times more likely to be diabetic compared with adults with a normal weight

This week's top managed care stories included the release of 7 core sets of quality measures, more evidence that value-based insurance design works to lower costs, and the FDA assigns breakthrough designation to AstraZeneca's PD-L1 inhibitor.

The scientists on the panel will advise JDRF on policy and research priorities as the organization supports major initiatives to cure type 1 diabetes or manage the disease.

FDA had halted work on the study drug after 2 deaths in an unrelated trial.

The clinical trial across 3 sites in California and Washington state will involve 300 participants and report results in 2017.

Individuals with more than one diagnosis are more likely to report to a primary care physician than to a subspecialty physician.

Deploying the algorithm in EHRs on a widepread basis could help find up to 400,000 Americans with undiagnosed diabetes, the researchers say.

This study identified 4 distinct medication adherence trajectories and found that continuity of care was consistently associated with medication adherence in every trajectory group.

There are 2 dimensions to patient centeredness of diabetes care that Lonny Reisman, MD, the founder and chief executive officer of HealthReveal, will focus on during his keynote speech at Patient-Centered Diabetes Care 2016.

The authors conclude that being overweight is not without risk, and their findings come after other estimates see the burden of chronic kidney disease increasing in the United States.

The results amplify earlier work at UAB that showed verapamil reversed type 1 diabetes in mice. A clinical trial involving the drug in recently diagnosed patients with type 1 disease is still enrolling participants.

The report on the Traditional Foods Project is part of CDC supplement on reducing healthcare disparities.

Using surgery to promote weight loss and improve health is associated with improve mortality. This study sought information on whether survival benefits extended to patients at higher ages.

The study, while small, suggests a scalable solution that would allow payers address diabetes prevention and health disparities.

Innovation has remained high on the administration’s agenda, as is evident from the allocations to tackle climate changes as well as find treatments for devastating health conditions.

Mexico is the perfect example of how Coke and Pepsi are investing heavily in the next generation of soda drinkers, and the country has the highest rates of obesity in the world.

It is common for persons with mental illness to suffer comorbid conditions.

The authors note that not only are insulin costs making type 1 diabetes deadly in the poorest nations; high costs are the leading reason for diabetic ketoacidosis in the inner cities in the United States.

The top stories in managed care this week included increased insurer concerns over the sustainability of the Affordable Care Act's insurance exchanges, healthy policy experts convened in DC, and 2 warnings for women to heed regarding pregnancy.

The findings are troubling in light of other recent findings that connect obesity during pregnancy with autism.

Another study that suggests sitting is "the new smoking."

Coordinating mental health and treatment of chronic disease has gained traction since the passage of the Affordable Care Act.

Medication adherence among patients with chronic conditions is estimated to cost $100 billion in North America.

Study finds a link between maternal obesity and diabetes and a significant increase in the risk of autism spectrum disorder in children.

The FDA has created the Drug Trial Snapshot, which provides details on the demographic profiles of participants in clinical trials of approved drugs.